颜葱, 涂晓璇, 吴伟, 童舟, 张航瑜, 刘璐璐, 郑怡, 赵鹏, 蒋微琴, 方维佳. 晚期肝癌综合治疗进展[J]. 中国肿瘤临床, 2018, 45(21): 1100-1103. DOI: 10.3969/j.issn.1000-8179.2018.21.899
引用本文: 颜葱, 涂晓璇, 吴伟, 童舟, 张航瑜, 刘璐璐, 郑怡, 赵鹏, 蒋微琴, 方维佳. 晚期肝癌综合治疗进展[J]. 中国肿瘤临床, 2018, 45(21): 1100-1103. DOI: 10.3969/j.issn.1000-8179.2018.21.899
Yan Cong, Tu Xiaoxuan, Wu Wei, Tong Zhou, Zhang Hangyu, Liu Lulu, Zheng Yi, Zhao Peng, Jiang Weiqin, Fang Weijia. Progress in comprehensive treatment of advanced hepatocellular carcinoma[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2018, 45(21): 1100-1103. DOI: 10.3969/j.issn.1000-8179.2018.21.899
Citation: Yan Cong, Tu Xiaoxuan, Wu Wei, Tong Zhou, Zhang Hangyu, Liu Lulu, Zheng Yi, Zhao Peng, Jiang Weiqin, Fang Weijia. Progress in comprehensive treatment of advanced hepatocellular carcinoma[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2018, 45(21): 1100-1103. DOI: 10.3969/j.issn.1000-8179.2018.21.899

晚期肝癌综合治疗进展

Progress in comprehensive treatment of advanced hepatocellular carcinoma

  • 摘要: 近年来,肝癌的发病率逐年上升,死亡率也位居前列。目前,手术治疗是肝癌唯一可能治愈的手段,但多数肝癌诊断时已属晚期,由于肝癌的异质性及对药物的敏感性各异,使得晚期肝癌的疗效较差。本文主要针对晚期肝癌治疗及晚期肝癌个体化治疗的重要进展进行综述,为临床进一步改善肝癌总生存提供新的思路。

     

    Abstract: In recent years, the incidence of hepatocellular carcinoma (HCC) has risen year by year, leading to a high mortality rate. At present, surgical treatment is the major cure for HCC, and in general, HCC is diagnosed at late stages. Due to the heterogeneity of HCC and different sensitivities to drugs, the treatment efficacy of advanced HCC is poor. In this paper, we retrospectively analyzed the progress of HCC treatments and reviewed important progression, which provides new view for the clinical improvement of the total survival of patients with HCC.

     

/

返回文章
返回